155 related articles for article (PubMed ID: 10837392)
1. Macrophage migration inhibitory factor levels in the vitreous of patients with proliferative diabetic retinopathy.
Mitamura Y; Takeuchi S; Matsuda A; Tagawa Y; Mizue Y; Nishihira J
Br J Ophthalmol; 2000 Jun; 84(6):636-9. PubMed ID: 10837392
[TBL] [Abstract][Full Text] [Related]
2. Macrophage migration inhibitory factor levels in the vitreous of patients with proliferative vitreoretinopathy.
Mitamura Y; Takeuchi S; Matsuda A; Tagawa Y; Mizue Y; Nishihira J
Am J Ophthalmol; 1999 Dec; 128(6):763-5. PubMed ID: 10612518
[TBL] [Abstract][Full Text] [Related]
3. Monocyte chemotactic protein-1 in the vitreous of patients with proliferative diabetic retinopathy.
Mitamura Y; Takeuchi S; Matsuda A; Tagawa Y; Mizue Y; Nishihira J
Ophthalmologica; 2001; 215(6):415-8. PubMed ID: 11741107
[TBL] [Abstract][Full Text] [Related]
4. Correlation between ficolin-3 and vascular endothelial growth factor-to-pigment epithelium-derived factor ratio in the vitreous of eyes with proliferative diabetic retinopathy.
Zheng B; Li T; Chen H; Xu X; Zheng Z
Am J Ophthalmol; 2011 Dec; 152(6):1039-43. PubMed ID: 21851923
[TBL] [Abstract][Full Text] [Related]
5. Elevated vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy.
Deng J; Wu DZ; Gao R
Yan Ke Xue Bao; 1999 Mar; 15(1):17-21. PubMed ID: 12579655
[TBL] [Abstract][Full Text] [Related]
6. Monocyte chemotactic protein-1 levels in the vitreous of patients with proliferative vitreoretinopathy.
Mitamura Y; Takeuchi S; Yamamoto S; Yamamoto T; Tsukahara I; Matsuda A; Tagawa Y; Mizue Y; Nishihira J
Jpn J Ophthalmol; 2002; 46(2):218-21. PubMed ID: 12062231
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of RAGE and its ligands in proliferative retinal disease.
Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
[TBL] [Abstract][Full Text] [Related]
8. Tenascin-C promotes angiogenesis in fibrovascular membranes in eyes with proliferative diabetic retinopathy.
Kobayashi Y; Yoshida S; Zhou Y; Nakama T; Ishikawa K; Arima M; Nakao S; Sassa Y; Takeda A; Hisatomi T; Ikeda Y; Matsuda A; Sonoda KH; Ishibashi T
Mol Vis; 2016; 22():436-45. PubMed ID: 27186070
[TBL] [Abstract][Full Text] [Related]
9. Soluble cellular adhesion molecules in proliferative vitreoretinopathy and proliferative diabetic retinopathy.
Barile GR; Chang SS; Park LS; Reppucci VS; Schiff WM; Schmidt AM
Curr Eye Res; 1999 Sep; 19(3):219-27. PubMed ID: 10487959
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte growth factor in vitreous fluid of patients with proliferative diabetic retinopathy and other retinal disorders.
Katsura Y; Okano T; Noritake M; Kosano H; Nishigori H; Kado S; Matsuoka T
Diabetes Care; 1998 Oct; 21(10):1759-63. PubMed ID: 9773744
[TBL] [Abstract][Full Text] [Related]
11. A comparison of sex steroid concentration levels in the vitreous and serum of patients with vitreoretinal diseases.
Nishikawa Y; Morishita S; Horie T; Fukumoto M; Sato T; Kida T; Oku H; Sugasawa J; Ikeda T; Nakamura K
PLoS One; 2017; 12(7):e0180933. PubMed ID: 28704441
[TBL] [Abstract][Full Text] [Related]
12. Soluble TNF receptors in vitreoretinal proliferative disease.
Limb GA; Hollifield RD; Webster L; Charteris DG; Chignell AH
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1586-91. PubMed ID: 11381065
[TBL] [Abstract][Full Text] [Related]
13. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
[TBL] [Abstract][Full Text] [Related]
14. Soluble IL-6 receptor in vitreous fluid of patients with proliferative diabetic retinopathy.
Kawashima M; Shoji J; Nakajima M; Kamura Y; Sato Y
Jpn J Ophthalmol; 2007; 51(2):100-4. PubMed ID: 17401618
[TBL] [Abstract][Full Text] [Related]
15. Elevated Activating Transcription Factor 4 and Glucose-Regulated 78 Kda Protein Levels Correlate with Inflammatory Cytokines in the Aqueous Humor and Vitreous of Proliferative Diabetic Retinopathy.
Wang Y; Gao S; Zhu Y; Shen X
Curr Eye Res; 2017 Aug; 42(8):1202-1208. PubMed ID: 28497987
[TBL] [Abstract][Full Text] [Related]
16. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R
Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of vitreous humor chemokines in type 2 diabetic patients with and without diabetic retinopathy.
Zeng Y; Cao D; Yu H; Hu Y; He M; Yang D; Zhuang X; Zhang L
Acta Diabetol; 2019 Jul; 56(7):797-805. PubMed ID: 30911832
[TBL] [Abstract][Full Text] [Related]
18. Aqueous levels of macrophage migration inhibitory factor and monocyte chemotactic protein-1 in patients with diabetic retinopathy.
Tashimo A; Mitamura Y; Nagai S; Nakamura Y; Ohtsuka K; Mizue Y; Nishihira J
Diabet Med; 2004 Dec; 21(12):1292-7. PubMed ID: 15569131
[TBL] [Abstract][Full Text] [Related]
19. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
Itakura H; Kishi S; Kotajima N; Murakami M
Ophthalmology; 2004 Oct; 111(10):1880-4. PubMed ID: 15465550
[TBL] [Abstract][Full Text] [Related]
20. Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
Elner SG; Elner VM; Jaffe GJ; Stuart A; Kunkel SL; Strieter RM
Curr Eye Res; 1995 Nov; 14(11):1045-53. PubMed ID: 8585935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]